{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T06:51:22Z","timestamp":1791701482694,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ejogrb.2023.03.014","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T18:48:13Z","timestamp":1679338093000},"page":"175-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Non-Excisional therapeutic modalities in vaginal intraepithelial neoplasia"],"prefix":"10.1016","volume":"284","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5493-6256","authenticated-orcid":false,"given":"Gon\u00e7alo","family":"Freitas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejogrb.2023.03.014_b0005","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/ijc.30275","article-title":"Randomised trial on treatment of vaginal intraepithelial neoplasia\u2014Imiquimod, laser vaporisation and expectant management","volume":"139","author":"Tainio","year":"2016","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.03.014_b0010","first-page":"383","article-title":"CO2 laser vaporization for the treatment of vaginal intraepithelial neoplasia: effectiveness and predictive factors for recurrence","volume":"36","author":"Piovano","year":"2015","journal-title":"Eur J Gynaecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.03.014_b0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11845-014-1231-z","article-title":"Clinical features, treatment and outcomes of vaginal intraepithelial neoplasia in a Chinese tertiary centre","volume":"185","author":"Chen","year":"2016","journal-title":"Ir J Med Sci"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.03.014_b0020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/LGT.0000000000000415","article-title":"5-Flouorouracil is an attractive medical treatment in women with vaginal intraepithelial neoplasia: a meta-analysis","volume":"22","author":"Tranoulis","year":"2018","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ejogrb.2023.03.014_b0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejogrb.2017.09.020","article-title":"Efficacy of 5% imiquimod for the treatment of Vaginal intraepithelial neoplasia\u2014A systematic review of the literature and a meta-analysis","volume":"218","author":"Tranoulis","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.03.014_b0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ygyno.2014.08.019","article-title":"Laser-skinning colpectomy for extended vaginal intraepithelial neoplasia and microinvasive cancer","volume":"135","author":"Luyten","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.03.014_b0035","unstructured":"Kurman RJ, Carcangiu ML, Herrington CS YR, editor. WHO Classification of Tumours of Female Reproductive Organs. 2014."},{"issue":"7","key":"10.1016\/j.ejogrb.2023.03.014_b0040","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4014\/jmb.1503.03106","article-title":"Efficacy of poly-gamma-glutamic acid in women with high-risk human papillomavirus-positive vaginal intraepithelial neoplasia: an observational pilot study","volume":"25","author":"Koo","year":"2015","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.ejogrb.2023.03.014_b0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejogrb.2016.12.020","article-title":"Human papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasia","volume":"210","author":"Bogani","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.03.014_b0050","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ygyno.2016.03.033","article-title":"Recurrence and risk of progression to lower genital tract malignancy in women with high grade VAIN","volume":"141","author":"Hodeib","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.03.014_b0055","first-page":"10","article-title":"Risk factors to develop multicentric lesions of the lower genital tract","volume":"38","author":"Gonz\u00e1lez Bosquet","year":"2017","journal-title":"Eur J Gynaecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.03.014_b0060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00404-015-3835-6","article-title":"Clinical presentation, treatment and outcome of vaginal intraepithelial neoplasia","volume":"293","author":"Jentschke","year":"2016","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.03.014_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3802\/jgo.2018.29.e6","article-title":"Clinical outcomes and risk of recurrence among patients with vaginal intraepithelial neoplasia: a comprehensive analysis of 576 cases","volume":"29","author":"Kim","year":"2018","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.03.014_b0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijgo.2015.08.014","article-title":"A retrospective study of 152 women with vaginal intraepithelial neoplasia","volume":"133","author":"Zhang","year":"2016","journal-title":"Int J Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.03.014_b0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/LGT.0000000000000326","article-title":"Laser excisional treatment for vaginal intraepithelial neoplasia to exclude invasion: what is the risk of complications?","volume":"21","author":"Sopracordevole","year":"2017","journal-title":"J Low Genit Tract Dis"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.03.014_b0080","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/AOG.0000000000002311","article-title":"Topical 5-fluorouracil forwomen with high-grade vaginal intraepithelial neoplasia","volume":"130","author":"Fiascone","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.03.014_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3802\/jgo.2019.30.e20","article-title":"Treatment modalities for recurrent high-grade vaginal intraepithelial neoplasia","volume":"30","author":"Bogani","year":"2019","journal-title":"J Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ejogrb.2023.03.014_b0090","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/lsm.22941","article-title":"LASER treatment for women with high-grade vaginal intraepithelial neoplasia: a propensity-matched analysis on the efficacy of ablative versus excisional procedures","volume":"50","author":"Bogani","year":"2018","journal-title":"Lasers Surg Med"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.03.014_b0095","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/jog.12383","article-title":"Therapeutic effect of laser vaporization for vaginal intraepithelial neoplasia following hysterectomy due to premalignant and malignant lesions","volume":"40","author":"Wang","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.03.014_b0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/LGT.0000000000000502","article-title":"Vaginal intraepithelial neoplasia: a retrospective study of treatment and outcomes among a cohort of UK women","volume":"24","author":"Field","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ejogrb.2023.03.014_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.101731","article-title":"Photodynamic therapy combined with carbon dioxide laser for low-grade vaginal intraepithelial neoplasia: a retrospective analysis","volume":"30","author":"Yao","year":"2020","journal-title":"Photodiagn Photodyn Ther"},{"key":"10.1016\/j.ejogrb.2023.03.014_b0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejogrb.2020.03.017","article-title":"Clinical outcomes of vaginectomy and laser ablation for the treatment of post-hysterectomy women with vaginal high-grade squamous intraepithelial lesions: a retrospective study","volume":"248","author":"Shen","year":"2020","journal-title":"Eur J Obstetr Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.03.014_b0115","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ijgo.13583","article-title":"Detection of high-risk human papillomavirus infection and treatment of high-grade vaginal intraepithelial neoplasia: a single-institution study","volume":"154","author":"Cho","year":"2021","journal-title":"Int J Gynecol Obstet"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.03.014_b0120","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/jog.14733","article-title":"Clinical presentation, treatment, and outcomes associated with vaginal intraepithelial neoplasia: a retrospective study of 118 patients","volume":"47","author":"Yu","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ejogrb.2023.03.014_b0125","article-title":"Recurrence of high-grade vaginal intraepithelial neoplasia after various treatments","author":"Boonlikit","year":"2021","journal-title":"Curr Probl Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.03.014_b0130","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ygyno.2021.06.027","article-title":"Risk factors analysis of persistence, progression and recurrence in vaginal intraepithelial neoplasia","volume":"162","author":"Ao","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.03.014_b0135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/LGT.0000000000000150","article-title":"Vaginal intraepithelial neoplasia: histopathological upgrading of lesions and evidence of occult vaginal cancer","volume":"20","author":"Sopracordevole","year":"2016","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ejogrb.2023.03.014_b0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejogrb.2015.08.018","article-title":"Brachytherapy for vaginal intraepithelial neoplasia","volume":"194","author":"Zolciak-Siwinska","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.03.014_b0145","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4143\/crt.2014.46.1.74","article-title":"High-dose-rate brachytherapy for the treatment of vaginal intraepithelial neoplasia","volume":"46","author":"Song","year":"2014","journal-title":"Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.03.014_b0150","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2020.09.031","article-title":"Imiquimod for vaginal intraepithelial neoplasia 2\u20133: a systematic review and meta-analysis","volume":"160","author":"Inayama","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.03.014_b0155","unstructured":"Aldara (Imiquimod) [prescribing information]. Bridgewater, NJ: Valeant Pharmaceuticals North America LLC; April 2018."},{"key":"10.1016\/j.ejogrb.2023.03.014_b0160","unstructured":"Efudex (Fluorouracil 5% cream) [prescribing information]. Bridgewater, NJ: Valeant Pharmaceuticals North America LLC; May 2017."},{"issue":"3","key":"10.1016\/j.ejogrb.2023.03.014_b0165","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00404-020-05441-5","article-title":"Accuracy of colposcopic findings in detecting vaginal intraepithelial neoplasia: a retrospective study","volume":"301","author":"Stuebs","year":"2020","journal-title":"Arch Gynecol Obstet"},{"issue":"10","key":"10.1016\/j.ejogrb.2023.03.014_b0170","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1158\/1078-0432.CCR-15-2594","article-title":"Vaccination against Oncoproteins of HPV16 for noninvasive vulvar\/vaginal lesions: lesion clearance is related to the strength of the T-Cell response","volume":"22","author":"Van Mar\u00efette","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"10108","key":"10.1016\/j.ejogrb.2023.03.014_b0175","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0140-6736(17)31821-4","article-title":"Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16\u201326 years: a randomised, double-blind trial","volume":"390","author":"Huh","year":"2017","journal-title":"Lancet"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523001045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523001045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:00:43Z","timestamp":1759557643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211523001045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":35,"alternative-id":["S0301211523001045"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.03.014","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-Excisional therapeutic modalities in vaginal intraepithelial neoplasia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}